Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models ; volume:69 ; number:1 ; day:5 ; month:12 ; year:2019 ; pages:135-145 ; date:1.2020
Cancer immunology immunotherapy ; 69, Heft 1 (5.12.2019), 135-145, 1.2020
- Creator
-
Zhang, Rui
Yuan, Fengjiao
Shu, Yang
Tian, Yaomei
Zhou, Bailing
Yi, Linglu
Zhang, Xueyan
Ding, Zhenyu
Xu, Heng
Yang, Li
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-019-02448-z
- URN
-
urn:nbn:de:101:1-2020041406505151541544
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Rui
- Yuan, Fengjiao
- Shu, Yang
- Tian, Yaomei
- Zhou, Bailing
- Yi, Linglu
- Zhang, Xueyan
- Ding, Zhenyu
- Xu, Heng
- Yang, Li
- SpringerLink (Online service)
Other Objects (12)
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Development of therapeutic vaccines for the treatment of diseases
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines
Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model
Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer
Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Development of therapeutic vaccines for the treatment of diseases
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines
Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model
Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer
Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Development of therapeutic vaccines for the treatment of diseases
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines
Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model
Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer